Thus, it can be seen that eIF3 subunits in NSCLC mainly exhibit proliferation-promoting, migration, invasion and apoptosis-inhibiting effects on cancer cells, and are expected to be potential targets for NSCLC therapy (Figure 2). Here, EIF3A is linked to non-small cell lung carcinoma.